1·Objective:To verify the new production of edaravone injection in line with quality standards, to meet sales demand.
目的：为了验证新生产的依达拉奉注射液符合质量标准，达到销售要求。
2·Objective To investigate the influence of edaravone on intestinal tissue ICAM-1 in intestinal barrier dysfunction after hemorrhagic shock of rabbits.
目的探讨依达拉奉在失血性休克中，对肠组织细胞间粘附分子- 1及肠屏障功能的影响。
3·Objective: To inquire the clinical effects and safety of edaravone injection in the treatment of traumatic cerebral infarction (TCI).
目的：探讨依达拉奉治疗外伤性脑梗死(TCI)的临床疗效和安全性。
4·Conclusion Edaravone can accelerate the recovery of neural function after acute cerebral infarction.
结论依达拉奉可促进急性脑梗死患者的神经功能康复。
5·Simcere calls Bicun a "first-to-market, branded generic drug." Edaravone has been investigated heavily in Japan for use as a neuroprotectant.
先声称必存为“市场第一，品牌的仿制药。”在日本，对依达拉奉作为一种神经保护剂进行了大量研究。